Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27805452 | 0.77 | FDPS (0.38) | — | |
| SCHEMBL27826107 | 0.77 | — | — | |
| SCHEMBL20299939 | 0.75 | FDPS (0.41) | TSHR | |
| SCHEMBL6920593 | 0.75 | — | — | |
| SCHEMBL21083259 | 0.75 | ALDH1A1 (0.30) | TSHR | |
| SCHEMBL8442801 | 0.75 | — | — | |
| SCHEMBL872202 | 0.71 | TSHR (0.33) | TSHR | |
| SCHEMBL5909039 | 0.69 | TSHR (0.32) | TSHR | |
| SCHEMBL11743054 | 0.69 | TSHR (0.33) | TSHR | |
| SCHEMBL10426544 | 0.69 | TSHR (0.55) | TSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3744175-B1 | COMPOSITION FOR IMPREGNATING A SUBSTRATE, IN PARTICULAR A WATCHSTRAP | ROLEX SA (CH) | 2024-05-29 | — | — | EP | disclosed |
| US-20040249147-A1 | Synthesis of key azole-antifungal intermediates | RANBAXY LABORATORIES LIMITED (IN) | 2004-12-09 | — | — | US | disclosed |
| US-6193950-B1 | FOR DIAGNOSIS AND THERAPY | SCHERING AG (DE) | 2001-02-27 | — | — | US | disclosed |
| US-4371725-A | Process for the preparation of tertiary olefins and n-alkanols | EC ERDOLCHEMIE GMBH (DE) | 1983-02-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20040249147-A1 | Synthesis of key azole-antifungal intermediates | ERG28, CYP11B1, CYP2E1 | TSHR 3948/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.